|
| Press Releases |
|
 |
|
| Tuesday, July 29, 2025 |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 22, 2025 |
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets |
| On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical Industry Growth Forum & CMS SGX Secondary Listing Appreciation Dinner". more info >> |
|
| Friday, July 18, 2025 |
|
|
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索 |
| 2025年7月15日，值此康哲药业控股有限公司（"康哲药业"或"集团"）成功于新加坡交易所（"新交所"）主板二次上市之际，由新交所与康哲药业联合主办的"新加坡及新兴市场医药产业发展论坛暨康哲药业新交所二次上市答谢晚宴"在集团位于新加坡大士的CDMO生产工厂PharmaGend盛大举行。 more info >> |
|
| Tuesday, July 15, 2025 |
|
|
耀啟新程！康哲藥業今日於新加坡交易所主板實現二次上市 |
| 康哲藥業控股有限公司（「康哲藥業」或「集團」）在新加坡交易所正式鳴鑼上市（證券簡稱：CMS，股票代碼：8A8）。 more info >> |
|
|
耀启新程！康哲药业今日于新加坡交易所主板实现二次上市 |
| 康哲药业控股有限公司（“康哲药业”或“集团”）在新加坡交易所正式鸣锣上市（证券简称：CMS，股票代码：8A8）。 more info >> |
|
| Wednesday, June 25, 2025 |
|
|
康哲药业建议于新加坡交易所第二上市 |
| 康哲药业控股有限公司（以下简称“康哲药业”）之董事会宣布，建议将其普通股（“股份”）以介绍方式于新加坡证券交易所有限公司（“新交所”）作第二上市（“建议第二上市”）。 more info >> |
|
|
康哲藥業建議於新加坡交易所第二上市 |
| 康哲藥業控股有限公司（以下簡稱「康哲藥業」）之董事會宣佈，建議將其普通股（「股份」）以介紹方式於新加坡證券交易所有限公司（「新交所」）作第二上市（「建議第二上市」）。 more info >> |
|
| Wednesday, March 19, 2025 |
|
|
康哲藥業（00867）發佈2024年度業績：聚焦創新與專科突破 重塑增長動能 |
| 康哲藥業發佈2024年度業績，公司全年實現營業收入人民幣74.69億元，同比下降6.8%；若全按藥品銷售收入計算，營業額為人民幣86.22億元，同比下降9.0%；實現淨利潤人民幣16.13億元，剔除相關資產減值損失計提後的正常化淨利潤為人民幣17.14億元 more info >> |
|
|
康哲药业（00867）发布2024年度业绩：聚焦创新与专科突破 重塑增长动能 |
| 康哲药业发布2024年度业绩，公司全年实现营业收入人民币74.69亿元，同比下降6.8%；若全按药品销售收入计算，营业额为人民币86.22亿元，同比下降9.0%；实现净利润人民币16.13亿元，剔除相关资产减值损失计提后的正常化净利润为人民币17.14亿元。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
New Report Reveals Key Considerations For Successful Distribution Onboarding
Jul 30, 2025 23:33 HKT/SGT
|
|
|
HKTDC welcomes the 'Report on Hong Kong's Business Environment' and continues to actively promote Hong Kong's advantages
Jul 30, 2025 22:40 HKT/SGT
|
|
|
Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition
Jul 30, 2025 22:40 HKT/SGT
|
|
|
New Report Reveals Key Considerations For Successful Distribution Onboarding
Jul 30, 2025 22:00: JST
|
|
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 30, 2025 22:00 HKT/SGT
|
|
|
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
|
|
|
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
Jul 30, 2025 19:56 HKT/SGT
|
|
|
Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition
Jul 30, 2025 19:29: JST
|
|
|
冠君產業信託三度舉辦ESG主題盛會 創新定義商廈價值與可持續未來
Jul 30, 2025 18:00 HKT/SGT
|
|
|
冠君产业信托三度举办ESG主题盛会 创新定义商厦价值与可持续未来
Jul 30, 2025 18:00 HKT/SGT
|
|
|
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
|
|
|
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
|
|
|
かんぽ生命、KKR及びGlobal Atlantic運用の再保険ビークルへ20億米ドルを投資
Jul 30, 2025 15:30: JST
|
|
|
Honda、2025年6月度 四輪車 生産・販売・輸出実績を発表
Jul 30, 2025 15:10: JST
|
|
|
トヨタ、2025年上半期 販売・生産・輸出実績を発表
Jul 30, 2025 13:30: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
